dc.contributor.author | Sağ, Elif | |
dc.contributor.author | Durmaz, Özlem | |
dc.contributor.author | Önal, Zerrin | |
dc.contributor.author | Tuğcu, Deniz | |
dc.contributor.author | Yücel, Esra | |
dc.contributor.author | Yılmaz, Tuğçe | |
dc.contributor.author | Leblebici, Uğur Can | |
dc.date.accessioned | 2023-10-10T10:49:01Z | |
dc.date.available | 2023-10-10T10:49:01Z | |
dc.identifier.citation | Yılmaz T., Leblebici U. C., Önal Z., Sağ E., Tuğcu D., Yücel E., Durmaz Ö., "RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?", ESPGHAN 55th Annual Meeeting, Vienna, Avusturya, 17 - 20 Mayıs 2023, ss.915 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0d0921a7-13b7-4f0a-aab8-1d2eaa725353 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/189523 | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE? | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.contributor.firstauthorID | 4574619 | |